Stimulant

1 marketed 2 in Phase 3

This page covers all Stimulant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting adenosine receptor.

Targets

adenosine receptor

Marketed (1)

Mild stimulation · UMC Utrecht · Neurology
Mild stimulation drugs work by increasing alertness and energy levels through the activation of certain neurotransmitters in the brain.

Phase 3 pipeline (2)

GP681 Simulant · Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Attention Deficit Hyperactivity Disorder (ADHD)
GP681 Simulant is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.
overencapsulated caffeine · Astellas Pharma Inc · Central Nervous System
Overencapsulated caffeine acts as a stimulant by increasing the levels of dopamine and norepinephrine in the brain.